
Flagship Pioneering, the bioplatform innovation company, and Invaio Sciences, a company bringing the technologies behind precision medicine to plant health, announced that Jonathan Schwartz will join Flagship Pioneering as CEO-Partner, and will be Chief Executive Officer and member of the Board at Invaio with immediate effect.
Dec 15, 2022 | agropages.comNow Flagship is formally launching Montai Health, which aims to treat chronic and complex diseases by using molecules found in foods, supplements and herbal medicines — natural compounds with a long history of human consumption.
Dec 13, 2022 | bizjournals.comFlagship Pioneering, the bioplatform innovation company, announced today that Pablo J. Cagnoni, M.D., will join as Executive Partner, effective November 15, 2022.
Nov 1, 2022 | flagshippioneering.comhC enters the fold a few months after Flagship Pioneering unveiled its own tRNA biotech, aptly named Alltrna.
Jan 1, 2022 | fiercebiotech.comDr. Austin joined Flagship in March of 2021 as CEO-Partner.
Jan 1, 2022 | biospace.comFlagship Pioneering, the bioplatform innovation company, has been named to Fast Company 's prestigious annual list of the World's Most Innovative Companies for 2022, ranking as the #2 most innovative company in North America.
Jan 1, 2022 | prnewswire.comFlagship Pioneering, the bioplatform innovation company, announced today that former Ancestry.com CEO Margo Georgiadis is joining Flagship as CEO-Partner.
Jan 1, 2022 | yahoo.comFlagship Pioneering, the bioplatform innovation company, today announced it has strengthened its executive leadership team with the appointment of Michelle C. Werner to the dual role of CEO-Partner of Flagship Pioneering and Chief Executive Officer of Alltrna.
Jan 1, 2022 | yahoo.comFlagship Pioneering, the bioplatform innovation company, announced today that Michael Severino, M.D., is joining the company as CEO-Partner.
Jan 1, 2022 | prnewswire.comFlagship Pioneering has partnered with Novo Nordisk to build a portfolio of potential treatments for cardiometabolic and rare diseases.
Jan 1, 2022 | biospace.comFlagship Pioneering has partnered with Novo Nordisk to build a portfolio of potential treatments for cardiometabolic and rare diseases.
Jan 1, 2022 | tmg360media.comMay 16, 2022 - Novo Nordisk and Flagship Pioneering recently collaborated to create a portfolio of novel research programs to develop transformation metabolic and rare disease treatments.
Jan 1, 2022 | pharmanewsintel.comFlagship Pioneering, the bioplatform innovation company, today unveiled ProFound™ Therapeutics, a company that has identified a universe of previously undiscovered human proteins, enabling a multitude of new therapeutic targets and medicines.
Jan 1, 2022 | valdostadailytimes.comFollowing his tenure with large pharma, Pomerantz joined Flagship Pioneering, where he was appointed president, chairman and chief executive officer of Seres Therapeutics.
Jan 1, 2022 | biospace.comFlagship Pioneering, the bioplatform innovation company, today announced the launch of Apriori Bio, a health security company aimed at providing humanity with variant-proof protection against rapidly evolving viruses.
Jan 1, 2022 | aprioribio.comIn May 2021, Flagship Pioneering launched LARONDE, a platform company developing Endless RNA™ ( eRNA ), a circular engineered form of RNA that can be programmed to express therapeutic proteins.
Jan 1, 2022 | knowmade.comCAMBRIDGE, Mass., May 10, 2021 /PRNewswire/ -- Flagship Pioneering today unveiled Laronde, a platform company developing Endless RNA™ (eRNA), a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body.
May 9, 2021 | prnewswire.comToday, the Cystic Fibrosis Foundation announced a first-of-its-kind collaboration with Pioneering Medicines, an initiative of Flagship Pioneering, to spur the development of genetic-based therapies for cystic fibrosis.
Jan 1, 2021 | businesswire.comThrough this agreement, Pioneering Medicines will combine technologies from several Flagship-founded companies to develop a separate company specifically focused on potential treatments for cystic fibrosis.
Jan 1, 2021 | cff.orgAxios reports that agtech startup Indigo Ag has raised around $300 million in new Series F funding from Flagship Pioneering, Alaska Permanent Fund and Riverstone Holdings.
Jan 1, 2018 | bizjournals.com